Biomarker: K082-IgE Latex

Overview

K082-IgE Latex measures serum immunoglobulin E (IgE) antibodies specific to natural rubber latex proteins. IgE participates in immediate hypersensitivity reactions by recognizing allergens and activating immune cells that release inflammatory mediators. Elevated latex-specific IgE indicates sensitization to latex but does not by itself confirm clinical allergy or predict reaction severity; a negative result also does not exclude allergy in every case. The test is clinically useful alongside exposure history and, when appropriate, skin testing to evaluate suspected IgE-mediated latex allergy.

Clinical Use Cases

Evaluation of suspected immediate latex allergy after exposure-related urticaria, angioedema, rhinitis, wheezing, asthma, or anaphylaxis.
Assessment of individuals with occupational latex exposure, including healthcare, dental, veterinary, hairdressing, and food-service workers.
Evaluation of patients with repeated surgical procedures or spina bifida, who may have increased latex exposure.
Supporting diagnosis when skin testing is unsuitable because of skin disease, medication effects, or concern about provoking a reaction.
Investigation of possible latex sensitization in patients with relevant food allergies, including banana, avocado, kiwi, or chestnut allergy.
Supplementing clinical history and skin testing when results are discordant or when assessment of occupational latex allergy is required.

Specimen Types

Venous blood, usually collected as serum.
Plasma may be accepted by some assay systems, according to the testing laboratory’s validated requirements.

Measurement Methods

Allergen-specific immunoassay for latex-specific IgE.
Fluorescent enzyme immunoassay, including ImmunoCAP-type methods.
Enzyme-linked immunosorbent assay or related enzyme immunoassays.
Older radioallergosorbent test methods may be described as RAST, although modern automated immunoassays are more commonly used.
Component-resolved immunoassays may measure IgE to individual latex allergens such as Hev b 5, Hev b 6.01, Hev b 6.02, or Hev b 8. These are distinct from the whole-latex K082 assay.

Test Preparation and Influencing Factors

Fasting is generally not required for a latex-specific IgE blood test.
Do not stop antihistamines or other medications unless instructed by a healthcare professional. Unlike skin testing, blood testing is generally less affected by antihistamines.
Results should be interpreted with the timing, route, and nature of latex exposure and the patient’s symptoms.
A positive result indicates sensitization, not necessarily symptomatic latex allergy.
Cross-reactivity with some plant, food, or pollen allergens and recognition of cross-reactive carbohydrate determinants may contribute to positive results without clinically significant latex allergy.
The measured IgE concentration does not reliably predict the severity of a future reaction.
Total IgE elevation, smoking, parasitic infection, and other allergic conditions may complicate interpretation of allergy blood testing.
Reactions caused by rubber-processing chemicals or other additives may represent type IV contact dermatitis and are not assessed by latex-specific IgE testing; patch testing may be more appropriate in that setting.